Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
James D. Chalmers (Perth, United Kingdom), Anthony De Soyza, Melissa J. McDonnell, John Davidson, Pieter C. Goeminne, Adam T. Hill, Eva Polverino, Stefano Aliberti, James D. Chalmers, On Behalf of EMBARC. Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry. Eur Respir J 2016; 48: Suppl. 60, 1541

Member's Comments

No comment yet.

Related content which might interest you: Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC) Source: International Congress 2016 – Clinical update on bronchiectasis Year: 2016 Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Exacerbations of bronchiectasis: Etiology and outcome Source: International Congress 2016 – Orphan diseases II Year: 2016 Childhood pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 The relationship between COPD and periodontitis Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Bronchiectasis is common in severe asthma Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Characterization of asthma exacerbations in outpatients – National survey Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC) Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Risk factors for idiopathic pulmonary fibrosis in Southern Europe: A case-control study Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Source: Eur Respir J, 56 (6) 2002857; 10.1183/13993003.02857-2020 Year: 2020